PTPRG has been characterized as a receptor‐type phosphatase with tumor‐suppressive functions in solid and hematologic malignancies, where its deletion, methylation, or downregulation unleashes oncogenic kinases such as ABL1 (12, 37). This evidence concerns the gene ABL1 and neoplasm.